The United States Food & Drug Administration (USFDA) completed a GMP inspection at our API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). We have been issued a Form 483 with 2 observations, which we will address within the stipulated timeline.